diagnostics

News

Gates Foundation backs digital diagnosis firm Audere

Digital health company Audere has been given a $9.3 million grant from the Bill & Melinda Gates Foundation for a project that aims to improve the accuracy of rapid dia

R&D

JP Morgan 2023 – Joe Spinelli

Editor-in-chief Jonah Comstock chats virtually with Aranscia's Joe Spinelli.

Patients

Nine for 2023, part two: healthcare’s hard problem, the prog...

The first part of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year,

News

FDA clears Polarean's lung disease diagnostic Xenoview

US medtech company Polarean Imaging has secured FDA approval for Xenoview, a drug device combination used alongside magnetic resonance imaging (MRI) to measure how well the lungs are functi

Oncology

Economist Impact: World Cancer Series – pharmaphorum in atte...

To conclude pharmaphorum’s look back at day one of The Economist’s 8th Annual World Cancer Series congress in Brussels, Belgium, in November – where the foci were “innovation, equity, and e

News

FDA says yes to MedCognetics breast cancer screening AI

Digital health company MedCognetics has picked up an FDA approval for QmTRIAGE, its artificial intelligence-powered software for detecting breast cancer in medical images.

Gates Foundation backs digital diagnosis firm Audere

JP Morgan 2023 – Joe Spinelli

Nine for 2023, part two: healthcare’s hard problem, the prog...

FDA clears Polarean's lung disease diagnostic Xenoview

Economist Impact: World Cancer Series – pharmaphorum in atte...

FDA says yes to MedCognetics breast cancer screening AI

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

diagnostics

Editor's Picks